C.J. FITZGERALD

C.J. Fitzgerald is a distinguished Managing Director at Summit Partners, a globally recognized growth equity firm. Based in the firm's Boston office, Mr. Fitzgerald plays a pivotal role in identifying and executing growth equity investments across a diverse range of high-growth sectors. His primary investment focus areas include enterprise software, healthcare technology, and technology-enabled services. He is known for his deep industry knowledge and his ability to partner with visionary management teams to drive significant value creation.

At Summit Partners, C.J. Fitzgerald leverages his extensive experience to support companies through various stages of growth, from initial investment to strategic exits. He is particularly adept at recognizing market trends and identifying innovative businesses poised for substantial expansion. His portfolio reflects a commitment to companies that are disrupting their respective industries through technological advancement and superior service delivery.

Prior to joining Summit Partners in 2007, Mr. Fitzgerald honed his financial acumen and investment expertise at other prominent institutions. He previously worked at TA Associates, another leading private equity firm, where he gained valuable experience in growth-oriented investments. Before his tenure at TA Associates, he began his career in the Investment Banking Division at Goldman Sachs, a global leader in financial services. This foundational experience provided him with a robust understanding of corporate finance, mergers and acquisitions, and capital markets. Mr. Fitzgerald is an alumnus of Harvard College, where he earned his undergraduate degree, further solidifying his strong academic background.

Throughout his career at Summit Partners, C.J. Fitzgerald has been instrumental in numerous successful investments. His notable contributions include investments in companies such as A Cloud Guru, a leading cloud computing training platform; Cloudmed, a healthcare revenue intelligence company later acquired by R1 RCM; CluePoints, a clinical data analytics firm; and Signavio, a business process management software company acquired by SAP. Other significant investments include Indegene, a digital transformation partner for life sciences; PartsSource, a healthcare operations platform; and PharmScript, a long-term care pharmacy provider. These investments highlight his consistent track record of identifying and nurturing companies that achieve market leadership and deliver strong returns. His strategic insights and hands-on approach make him a valuable partner to the entrepreneurs and executives he works with, helping them navigate complex market landscapes and achieve their strategic objectives.